SAFIR01: First large scale trial of whole-genome cancer testing for clinical decision-making

For the first time, researchers have conducted a large trial in which they tested the entire genome from a biopsy of a metastatic lesion prospectively for individual patients with metastatic breast cancer to help personalize treatment. They presented their findings at the European Society for Medical Oncology's ESMO2012 Congress in Vienna. Read more here.